Click for best price

Molecular Diagnostics Cancer Market Size, Share 2022

Market Analysis and Insights: Global Molecular Diagnostics Cancer Market

The global Molecular Diagnostics Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics Cancer market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics Cancer market.

Global Molecular Diagnostics Cancer Scope and Market Size

Molecular Diagnostics Cancer market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Pharmacogenomic Diagnosis

Liquid Biopsy

Other

Segment by Application

Respiratory Cancer

Cancer of Digestive System

Cancer of Urinary System

Cancer of Circulatory System

Motor System Cancer

Reproductive System Cancer

Other

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Roche

Danaher

Siemens

Abbott Laboratories

ICON Plc

AstraZeneca

MDxHealth

Invitae

PlexBio

Thermo Fisher Scientific

Guardant Health

Biocartis

Bio-Techne

Merck

Foundation Medicine

10X Genomics

Biodesix

CytoTrack

GenomOncology

Luminex

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Molecular Diagnostics Cancer product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Molecular Diagnostics Cancer, with price, sales, revenue, and global market share of Molecular Diagnostics Cancer from 2019 to 2022.

Chapter 3, the Molecular Diagnostics Cancer competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Molecular Diagnostics Cancer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Molecular Diagnostics Cancer market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Cancer.

Chapter 13, 14, and 15, to describe Molecular Diagnostics Cancer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Molecular Diagnostics Cancer Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Molecular Diagnostics Cancer Market Research Report 2022
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	114 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Pharmacogenomic Diagnosis
1.2.3 Liquid Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Cancer Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Respiratory Cancer
1.3.3 Cancer of Digestive System
1.3.4 Cancer of Urinary System
1.3.5 Cancer of Circulatory System
1.3.6 Motor System Cancer
1.3.7 Reproductive System Cancer
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Cancer Market Perspective (2017-2028)
2.2 Molecular Diagnostics Cancer Growth Trends by Region
2.2.1 Molecular Diagnostics Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Cancer Market Dynamics
2.3.1 Molecular Diagnostics Cancer Industry Trends
2.3.2 Molecular Diagnostics Cancer Market Drivers
2.3.3 Molecular Diagnostics Cancer Market Challenges
2.3.4 Molecular Diagnostics Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2021
3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Cancer Breakdown Data by Type
4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Cancer Breakdown Data by Application
5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Cancer Market Size (2017-2028)
6.2 North America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
6.3 North America Molecular Diagnostics Cancer Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Molecular Diagnostics Cancer Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022)
7.3 Europe Molecular Diagnostics Cancer Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Country (2017-2022)
8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Cancer Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
9.3 Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022)
10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Molecular Diagnostics Cancer Introduction
11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Molecular Diagnostics Cancer Introduction
11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.2.5 Danaher Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Molecular Diagnostics Cancer Introduction
11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.3.5 Siemens Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.4.5 Abbott Laboratories Recent Development
11.5 ICON Plc
11.5.1 ICON Plc Company Detail
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.5.5 ICON Plc Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.6.5 AstraZeneca Recent Development
11.7 MDxHealth
11.7.1 MDxHealth Company Detail
11.7.2 MDxHealth Business Overview
11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.7.5 MDxHealth Recent Development
11.8 Invitae
11.8.1 Invitae Company Detail
11.8.2 Invitae Business Overview
11.8.3 Invitae Molecular Diagnostics Cancer Introduction
11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.8.5 Invitae Recent Development
11.9 PlexBio
11.9.1 PlexBio Company Detail
11.9.2 PlexBio Business Overview
11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.9.5 PlexBio Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Detail
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.11.5 Guardant Health Recent Development
11.12 Biocartis
11.12.1 Biocartis Company Detail
11.12.2 Biocartis Business Overview
11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.12.5 Biocartis Recent Development
11.13 Bio-Techne
11.13.1 Bio-Techne Company Detail
11.13.2 Bio-Techne Business Overview
11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.13.5 Bio-Techne Recent Development
11.14 Merck
11.14.1 Merck Company Detail
11.14.2 Merck Business Overview
11.14.3 Merck Molecular Diagnostics Cancer Introduction
11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.14.5 Merck Recent Development
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Detail
11.15.2 Foundation Medicine Business Overview
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.15.5 Foundation Medicine Recent Development
11.16 10X Genomics
11.16.1 10X Genomics Company Detail
11.16.2 10X Genomics Business Overview
11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.16.5 10X Genomics Recent Development
11.17 Biodesix
11.17.1 Biodesix Company Detail
11.17.2 Biodesix Business Overview
11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.17.5 Biodesix Recent Development
11.18 CytoTrack
11.18.1 CytoTrack Company Detail
11.18.2 CytoTrack Business Overview
11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.18.5 CytoTrack Recent Development
11.19 GenomOncology
11.19.1 GenomOncology Company Detail
11.19.2 GenomOncology Business Overview
11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.19.5 GenomOncology Recent Development
11.20 Luminex
11.20.1 Luminex Company Detail
11.20.2 Luminex Business Overview
11.20.3 Luminex Molecular Diagnostics Cancer Introduction
11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.20.5 Luminex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Pharmacogenomic Diagnosis
Table 3. Key Players of Liquid Biopsy
Table 4. Key Players of Other
Table 5. Global Molecular Diagnostics Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Molecular Diagnostics Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Molecular Diagnostics Cancer Market Share by Region (2017-2022)
Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Molecular Diagnostics Cancer Market Share by Region (2023-2028)
Table 11. Molecular Diagnostics Cancer Market Trends
Table 12. Molecular Diagnostics Cancer Market Drivers
Table 13. Molecular Diagnostics Cancer Market Challenges
Table 14. Molecular Diagnostics Cancer Market Restraints
Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Molecular Diagnostics Cancer Market Share by Players (2017-2022)
Table 17. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021)
Table 18. Ranking of Global Top Molecular Diagnostics Cancer Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Cancer Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2017-2022)
Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2023-2028)
Table 28. Global Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2017-2022)
Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2023-2028)
Table 32. North America Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 42. Roche Company Detail
Table 43. Roche Business Overview
Table 44. Roche Molecular Diagnostics Cancer Product
Table 45. Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 46. Roche Recent Development
Table 47. Danaher Company Detail
Table 48. Danaher Business Overview
Table 49. Danaher Molecular Diagnostics Cancer Product
Table 50. Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 51. Danaher Recent Development
Table 52. Siemens Company Detail
Table 53. Siemens Business Overview
Table 54. Siemens Molecular Diagnostics Cancer Product
Table 55. Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 56. Siemens Recent Development
Table 57. Abbott Laboratories Company Detail
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Molecular Diagnostics Cancer Product
Table 60. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. ICON Plc Company Detail
Table 63. ICON Plc Business Overview
Table 64. ICON Plc Molecular Diagnostics Cancer Product
Table 65. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 66. ICON Plc Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Molecular Diagnostics Cancer Product
Table 70. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. MDxHealth Company Detail
Table 73. MDxHealth Business Overview
Table 74. MDxHealth Molecular Diagnostics Cancer Product
Table 75. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 76. MDxHealth Recent Development
Table 77. Invitae Company Detail
Table 78. Invitae Business Overview
Table 79. Invitae Molecular Diagnostics Cancer Product
Table 80. Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 81. Invitae Recent Development
Table 82. PlexBio Company Detail
Table 83. PlexBio Business Overview
Table 84. PlexBio Molecular Diagnostics Cancer Product
Table 85. PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 86. PlexBio Recent Development
Table 87. Thermo Fisher Scientific Company Detail
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Molecular Diagnostics Cancer Product
Table 90. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 91. Thermo Fisher Scientific Recent Development
Table 92. Guardant Health Company Detail
Table 93. Guardant Health Business Overview
Table 94. Guardant Health Molecular Diagnostics CancerProduct
Table 95. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 96. Guardant Health Recent Development
Table 97. Biocartis Company Detail
Table 98. Biocartis Business Overview
Table 99. Biocartis Molecular Diagnostics CancerProduct
Table 100. Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 101. Biocartis Recent Development
Table 102. Bio-Techne Company Detail
Table 103. Bio-Techne Business Overview
Table 104. Bio-Techne Molecular Diagnostics CancerProduct
Table 105. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 106. Bio-Techne Recent Development
Table 107. Merck Company Detail
Table 108. Merck Business Overview
Table 109. Merck Molecular Diagnostics CancerProduct
Table 110. Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 111. Merck Recent Development
Table 112. Foundation Medicine Company Detail
Table 113. Foundation Medicine Business Overview
Table 114. Foundation Medicine Molecular Diagnostics CancerProduct
Table 115. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 116. Foundation Medicine Recent Development
Table 117. 10X Genomics Company Detail
Table 118. 10X Genomics Business Overview
Table 119. 10X Genomics Molecular Diagnostics CancerProduct
Table 120. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 121. 10X Genomics Recent Development
Table 122. Biodesix Company Detail
Table 123. Biodesix Business Overview
Table 124. Biodesix Molecular Diagnostics CancerProduct
Table 125. Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 126. Biodesix Recent Development
Table 127. CytoTrack Company Detail
Table 128. CytoTrack Business Overview
Table 129. CytoTrack Molecular Diagnostics CancerProduct
Table 130. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 131. CytoTrack Recent Development
Table 132. GenomOncology Company Detail
Table 133. GenomOncology Business Overview
Table 134. GenomOncology Molecular Diagnostics CancerProduct
Table 135. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 136. GenomOncology Recent Development
Table 137. Luminex Company Detail
Table 138. Luminex Business Overview
Table 139. Luminex Molecular Diagnostics CancerProduct
Table 140. Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 141. Luminex Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2021 VS 2028
Figure 2. Pharmacogenomic Diagnosis Features
Figure 3. Liquid Biopsy Features
Figure 4. Other Features
Figure 5. Global Molecular Diagnostics Cancer Market Share by Application in 2021 & 2028
Figure 6. Respiratory Cancer Case Studies
Figure 7. Cancer of Digestive System Case Studies
Figure 8. Cancer of Urinary System Case Studies
Figure 9. Cancer of Circulatory System Case Studies
Figure 10. Motor System Cancer Case Studies
Figure 11. Reproductive System Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Molecular Diagnostics Cancer Report Years Considered
Figure 14. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Molecular Diagnostics Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Molecular Diagnostics Cancer Market Share by Region: 2021 VS 2028
Figure 17. Global Molecular Diagnostics Cancer Market Share by Players in 2021
Figure 18. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2021
Figure 20. North America Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Molecular Diagnostics Cancer Market Share by Country (2017-2028)
Figure 22. United States Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Molecular Diagnostics Cancer Market Share by Country (2017-2028)
Figure 26. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Molecular Diagnostics Cancer Market Share by Region (2017-2028)
Figure 34. China Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Molecular Diagnostics Cancer Market Share by Country (2017-2028)
Figure 42. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Molecular Diagnostics Cancer Market Share by Country (2017-2028)
Figure 46. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 49. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 50. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 51. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 52. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 53. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 54. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 55. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 56. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 58. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 59. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 60. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 61. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 62. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 63. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 64. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 65. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 66. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 67. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Molecular Diagnostics Cancer Market Research Report 2022